The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ABSCI CORPORATION | COM | 00091E109 | 5,822,000 | 1,025,000 | SH | SOLE | 1,025,000 | 0 | 0 | |||
AKERO THERAPEUTICS INC | COM | 00973Y108 | 1,894,500 | 75,000 | SH | Call | SOLE | 75,000 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 2,030,250 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | |||
ALNYLAM PHARMACEUTICALS INC | NOTE 1.000% 9/1 | 02043QAB3 | 9,448,755 | 10,000,000 | PRN | SOLE | 10,000,000 | 0 | 0 | |||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 5,978,000 | 40,000 | SH | Call | SOLE | 40,000 | 0 | 0 | ||
ANNOVIS BIO INC | COM | 03615A108 | 867,510 | 72,900 | SH | Put | SOLE | 72,900 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 9,698,700 | 165,000 | SH | SOLE | 165,000 | 0 | 0 | |||
APOGEE THERAPEUTICS INC | COM | 03770N101 | 39,344,580 | 592,093 | SH | SOLE | 592,093 | 0 | 0 | |||
ARCELLX INC | COMMON STOCK | 03940C100 | 20,865,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 3,432,000 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | |||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 1,504,545 | 133,500 | SH | SOLE | 133,500 | 0 | 0 | |||
ASTRIA THERAPEUTICS INC | COM | 04635X102 | 11,901,904 | 845,606 | SH | SOLE | 845,606 | 0 | 0 | |||
AUTOLUS THERAPEUTICS PLC | SPON ADS | 05280R100 | 21,532,500 | 3,375,000 | SH | SOLE | 3,375,000 | 0 | 0 | |||
AVALO THERAPEUTICS INC | COM NEW | 05338F306 | 217,500 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
AVROBIO INC | COM | 05455M100 | 896,000 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | |||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 11,152,688 | 139,758 | SH | SOLE | 139,758 | 0 | 0 | |||
BEIGENE LTD | SPONSORED ADR | 07725L102 | 12,846,344 | 82,143 | SH | SOLE | 82,143 | 0 | 0 | |||
BOSTON SCIENTIFIC CORP | COM | 101137107 | 1,712,250 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | |||
BRIDGEBIO PHARMA INC | NOTE 2.500% 3/1 | 10806XAB8 | 18,298,257 | 17,000,000 | PRN | SOLE | 17,000,000 | 0 | 0 | |||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 7,730,000 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | ||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 1,546,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
CASSAVA SCIENCES INC | W EXP 11/15/202 | 14817C115 | 97,524 | 24,200 | SH | SOLE | 24,200 | 0 | 0 | |||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | 21,404,700 | 510,000 | SH | SOLE | 510,000 | 0 | 0 | |||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 9,385,170 | 830,546 | SH | SOLE | 830,546 | 0 | 0 | |||
CEREVEL THERAPEUTICS HLDNG I | COM | 15678U128 | 12,681,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
COHERUS BIOSCIENCES INC | NOTE 1.500% 4/1 | 19249HAB9 | 5,784,786 | 9,000,000 | PRN | SOLE | 9,000,000 | 0 | 0 | |||
COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | 8,551,862 | 1,027,868 | SH | SOLE | 1,027,868 | 0 | 0 | |||
CONTEXT THERAPEUTICS INC | COM | 21077P108 | 453,767 | 328,817 | SH | SOLE | 328,817 | 0 | 0 | |||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 22,000,700 | 470,000 | SH | SOLE | 470,000 | 0 | 0 | |||
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | 4,430,400 | 65,000 | SH | Call | SOLE | 65,000 | 0 | 0 | ||
CULLINAN ONCOLOGY INC | COM | 230031106 | 4,406,340 | 258,588 | SH | SOLE | 258,588 | 0 | 0 | |||
CYTOKINETICS INC | COM NEW | 23282W605 | 5,608,800 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | |||
ELEVATION ONCOLOGY INC | COM | 28623U101 | 6,509,072 | 1,268,825 | SH | SOLE | 1,268,825 | 0 | 0 | |||
ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 8,377,580 | 164,589 | SH | SOLE | 164,589 | 0 | 0 | |||
ESTABLISHMENT LABS HLDGS INC | COM | G31249108 | 2,545,000 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 5,195,200 | 550,339 | SH | SOLE | 550,339 | 0 | 0 | |||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 2,596,000 | 275,000 | SH | Call | SOLE | 275,000 | 0 | 0 | ||
GERON CORP | COM | 374163103 | 8,250,000 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | |||
GLYCOMIMETICS INC | COM | 38000Q102 | 426,900 | 142,300 | SH | Put | SOLE | 142,300 | 0 | 0 | ||
GRITSTONE BIO INC | COM | 39868T105 | 6,143,842 | 2,390,600 | SH | Put | SOLE | 2,390,600 | 0 | 0 | ||
GUARDANT HEALTH INC | COM | 40131M109 | 5,157,500 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | ||
HELIX ACQUISITION CORP II | CL A ORD SHS | G4444H101 | 2,587,500 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | |||
IMMATICS N.V | SHS | N44445109 | 3,678,500 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | |||
IMMATICS N.V | W EXP 07/01/202 | N44445117 | 486,730 | 187,204 | SH | SOLE | 187,204 | 0 | 0 | |||
IMMUNITYBIO INC | COM | 45256X103 | 3,165,078 | 589,400 | SH | Put | SOLE | 589,400 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 9,208,350 | 285,000 | SH | SOLE | 285,000 | 0 | 0 | |||
IMMUNOVANT INC | COM | 45258J102 | 4,665,564 | 144,400 | SH | Call | SOLE | 144,400 | 0 | 0 | ||
INARI MED INC | COM | 45332Y109 | 8,396,500 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | |||
INOZYME PHARMA INC | COM | 45790W108 | 20,241,696 | 2,642,519 | SH | SOLE | 2,642,519 | 0 | 0 | |||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 3,460,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | 8,966,945 | 1,029,500 | SH | Call | SOLE | 1,029,500 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 1,588,419 | 1,761,778 | SH | SOLE | 1,761,778 | 0 | 0 | |||
KRYSTAL BIOTECH INC | COM | 501147102 | 4,758,916 | 26,746 | SH | SOLE | 26,746 | 0 | 0 | |||
KURA ONCOLOGY INC | COM | 50127T109 | 15,581,394 | 730,492 | SH | SOLE | 730,492 | 0 | 0 | |||
MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | 30,709,600 | 115,000 | SH | SOLE | 115,000 | 0 | 0 | |||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 4,480,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | |||
MINERALYS THERAPEUTICS INC | COM | 603170101 | 4,233,951 | 327,959 | SH | SOLE | 327,959 | 0 | 0 | |||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 4,019,200 | 160,000 | SH | SOLE | 160,000 | 0 | 0 | |||
MODERNA INC | COM | 60770K107 | 42,624,000 | 400,000 | SH | Put | SOLE | 400,000 | 0 | 0 | ||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 3,767,250 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | |||
MORPHIC HLDG INC | COM | 61775R105 | 7,920,000 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | |||
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | N62509109 | 6,768,630 | 286,200 | SH | SOLE | 286,200 | 0 | 0 | |||
NEWAMSTERDAM PHARMA COMPANY | W EXP 11/22/202 | N62509117 | 2,236,693 | 202,599 | SH | SOLE | 202,599 | 0 | 0 | |||
NEXTCURE INC | COM | 65343E108 | 3,030,653 | 1,359,037 | SH | SOLE | 1,359,037 | 0 | 0 | |||
NURIX THERAPEUTICS INC | COM | 67080M103 | 11,910,719 | 810,253 | SH | SOLE | 810,253 | 0 | 0 | |||
NUVALENT INC | COM | 670703107 | 11,263,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
OMEROS CORP | NOTE 5.250% 2/1 | 682143AG7 | 7,632,450 | 10,500,000 | PRN | SOLE | 10,500,000 | 0 | 0 | |||
PASSAGE BIO INC | COM | 702712100 | 356,759 | 264,266 | SH | SOLE | 264,266 | 0 | 0 | |||
PERSPECTIVE THERAPEUTICS INC | COM | 46489V104 | 6,069,000 | 5,100,000 | SH | SOLE | 5,100,000 | 0 | 0 | |||
PROMIS NEUROSCIENCES INC | COM NEW | 74346M406 | 507,980 | 265,958 | SH | SOLE | 0 | 0 | 0 | |||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 2,893,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
Q32 BIO INC | COM | 746964105 | 473,320 | 27,777 | SH | SOLE | 27,777 | 0 | 0 | |||
RAPT THERAPEUTICS INC | COM | 75382E109 | 5,182,358 | 577,100 | SH | Put | SOLE | 577,100 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 538,800 | 60,000 | SH | Call | SOLE | 60,000 | 0 | 0 | ||
REGENXBIO INC | COM | 75901B107 | 2,317,700 | 110,000 | SH | SOLE | 110,000 | 0 | 0 | |||
REZOLUTE INC | COM NEW | 76200L309 | 4,080,000 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | |||
ROCKET PHARMACEUTICALS INC | W EXP 09/02/202 | 77313F114 | 22,440 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | |||
ROIVANT SCIENCES LTD | SHS | G76279101 | 5,270,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | |||
SAVARA INC | COM | 805111101 | 5,727,000 | 1,150,000 | SH | SOLE | 1,150,000 | 0 | 0 | |||
SPDR SER TR | S&P BIOTECH | 78464A870 | 66,423,000 | 700,000 | SH | Put | SOLE | 700,000 | 0 | 0 | ||
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 4,922,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 15,551,300 | 410,000 | SH | SOLE | 410,000 | 0 | 0 | |||
TANGO THERAPEUTICS INC | COM | 87583X109 | 1,193,176 | 150,274 | SH | SOLE | 150,274 | 0 | 0 | |||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 2,952,000 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | |||
TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 881624209 | 23,352,050 | 1,655,000 | SH | Call | SOLE | 1,655,000 | 0 | 0 | ||
TEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 881624209 | 19,754,000 | 1,400,000 | SH | SOLE | 1,400,000 | 0 | 0 | |||
TOURMALINE BIO INC | COM | 89157D105 | 1,145,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 963,750 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | |||
VAXCYTE INC | COM | 92243G108 | 5,464,800 | 80,000 | SH | SOLE | 80,000 | 0 | 0 | |||
VERA THERAPEUTICS INC | CL A | 92337R101 | 20,266,400 | 470,000 | SH | SOLE | 470,000 | 0 | 0 | |||
VERONA PHARMA PLC | SPONSORED ADS | 925050106 | 13,158,933 | 817,833 | SH | SOLE | 817,833 | 0 | 0 | |||
VIKING THERAPEUTICS INC | COM | 92686J106 | 4,100,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 1,768,229 | 286,585 | SH | SOLE | 286,585 | 0 | 0 | |||
XENON PHARMACEUTICALS INC | COM | 98420N105 | 36,049,510 | 837,387 | SH | SOLE | 837,387 | 0 | 0 | |||
ZURA BIO LTD | CLASS A ORD SHS | G9TY5A101 | 1,156,523 | 450,009 | SH | SOLE | 450,009 | 0 | 0 |